Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Centrosome aberrations and cancer.

A Krämer1, A D Ho

  • 1Medizinische Klinik und Poliklinik V, Ruprecht-Karls-Universität Heidelberg, Germany. Alwin_Kraemer@med.uni-heidelberg.de

Onkologie
|January 19, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rituximab Chimeric Anti-CD20 Monoclonal Antibody Therapy for Relapsed Indolent Lymphoma: Half of Patients Respond to a Four-Dose Treatment Program.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2023
Same author

An automated approach to determine antibody endpoint titers for COVID-19 by an enzyme-linked immunosorbent assay.

Immunohematology·2021
Same author

Transplant-associated thrombotic microangiopathy is an endothelial complication associated with refractoriness of acute GvHD.

Bone marrow transplantation·2017
Same author

Addition of rituximab to CHOP-like chemotherapy in first line treatment of primary mediastinal B-cell lymphoma.

BMC cancer·2017
Same author

Molecular signaling in multiple myeloma: association of RAS/RAF mutations and MEK/ERK pathway activation.

Oncogenesis·2017
Same author

GvL effects in T-prolymphocytic leukemia: evidence from MRD kinetics and TCR repertoire analyses.

Bone marrow transplantation·2017

Errors in centrosome duplication lead to abnormal cell division and aneuploidy, contributing to cancer. Aberrant centrosome replication is a key factor in human neoplasias, driving karyotypic instability and uncontrolled proliferation.

Area of Science:

  • Cell Biology
  • Cancer Biology
  • Genetics

Background:

  • Karyotypic alterations are common in cancer cells.
  • Errors in centrosome duplication can cause aneuploidy and contribute to cancer formation.
  • Supernumerary centrosomes are frequently observed in human tumors.

Purpose of the Study:

  • To review the causes and consequences of aberrant centrosome replication in human neoplasias.
  • To highlight the link between cell cycle regulation and centrosome duplication errors.
  • To discuss the role of centrosome abnormalities in cancer development.

Main Methods:

  • Literature review of studies on cell cycle regulation, centrosome duplication, and cancer.
  • Analysis of molecular mechanisms linking cell division cycle to centrosome replication.

Related Experiment Videos

  • Examination of frequent aberrations in regulatory proteins in human malignancies.

    • Main Results:

    • Aberrant centrosome replication leads to abnormal chromosome segregation and aneuploidy.
    • Alterations in cell cycle regulatory proteins (e.g., p53, cyclins, CDKs) are frequent in cancers.
    • Uncontrolled centrosome replication contributes to karyotypic instability and unrestrained proliferation.

    Conclusions:

    • Errors in the centrosome duplication cycle are a significant cause of aneuploidy and cancer.
    • Aberrant centrosome replication plays a crucial role in the development and progression of human neoplasias.
    • Targeting cell cycle and centrosome regulation may offer therapeutic strategies for cancer.